Preliminary Data
Last Update Q1 2022
| Industry Range | | Price / Earnings | N/A | |
| Book Value | 1.76 | |
| Earnings Per Share | -$3.20 | |
| Price To Sales Ratio | 65.08 | |
| Price To Book Ratio | 28.54 | |
| Price To Tangible Book Ratio | 28.55 | |
| Price/Cash Flow Ratio | N/A | |
| Price/Free Cash Flow Ratio | N/A | |
| Industry Range | | Market Capitalization | 3.6B | |
| Float (MRQ) | 93.98% | |
| Shares Outstanding (MRQ) | 84.1M | |
| Short Interest as a % of Float (MRQ) | 9.82% | |
| Shares Held By Institutions (MRQ) | 33.5M | |
| Industry Range | | Sales | $70.4M | |
| Gross Margin | 96.18% | |
| Net Profit Margin | -365.84% | |
| EBIT Margin | -317.43% | |
| EBITDA Margin | -193.96% | |
| Operating Margins | -264.54% | |
All fundamentals are Trailing Twelve Months (TTM) unless noted. Preliminary data is based on the company's 8-K
statement or press releases. MRQ = Most Recent Quarter
| Industry Range | | Current Ratio (MRQ) | 7.45 | |
| Quick Ratio (MRQ) | 7.45 | |
| Total Debt/Equity Ratio (MRQ) | 277.13 | |
| Debt/Common Equity Ratio (MRQ) | 277.13 | |
| Industry Range | | Return on Equity | -178.55% | |
| Return on Assets | -56.38% | |
| Asset Turnover | 0.15 | |
| Receivables Turnover | 5.11 | |
| Inventory Turnover | N/A | |
| Industry Range | | EPS Growth Annual | 40.80% | |
| Dividend Yield 5 Year Average | 0.00% | |
| Current Dividend Yield | 0.00% | |
| Current Payout Ratio | N/A | |
*CYTK does not pay a dividend. The average dividend yield for companies in the Pharmaceuticals: Major industry is 2.22%